Clinical Trial Update: Trial of Curcumin in Cutaneous T-cell Lymphoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial of curcumin in patients with cutaneous T-cell lymphoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cutaneous T-cell Lymphoma | Phase 2 | Status: WITHDRAWN